Cargando…
2021年非小细胞肺癌重要临床研究纵观与解读
Though the coronavirus disease is still raging in 2021, clinical research on non-small cell lung cancer (NSCLC) did not stop. However, benefiting from advances in lung cancer treatment modality, NSCLC patients have experienced significant improvements in overall survival and quality of life. Current...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127757/ https://www.ncbi.nlm.nih.gov/pubmed/35570145 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.19 |